-+ 0.00%
-+ 0.00%
-+ 0.00%

Colon Pharmaceutical announced that according to the “2026 Drug Catalogue” issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security, the company and its holding subsidiaries have included a total of 4 varieties, including 3 new drugs and 1 with 2 new indications. The total sales volume of these drugs in 2025 was 521 million yuan, and the total sales volume from January to June 2026 was 543 million yuan, accounting for about 2.82% and 6.15% of the company's revenue for the same period, respectively. The 2026 Drug Catalogue will be officially implemented on January 1, 2027.

Zhitongcaijing·11/16/2026 09:49:18
Listen to the news
Colon Pharmaceutical announced that according to the “2026 Drug Catalogue” issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security, the company and its holding subsidiaries have included a total of 4 varieties, including 3 new drugs and 1 with 2 new indications. The total sales volume of these drugs in 2025 was 521 million yuan, and the total sales volume from January to June 2026 was 543 million yuan, accounting for about 2.82% and 6.15% of the company's revenue for the same period, respectively. The 2026 Drug Catalogue will be officially implemented on January 1, 2027.